163 related articles for article (PubMed ID: 2361563)
1. Determination of replacement and suppressive doses of thyroxine.
Banovac K; Carrington SA; Levis S; Fill MD; Bilsker MS
J Int Med Res; 1990; 18(3):210-8. PubMed ID: 2361563
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
[TBL] [Abstract][Full Text] [Related]
3. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
[TBL] [Abstract][Full Text] [Related]
5. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
Konno N; Morikawa K
J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
[TBL] [Abstract][Full Text] [Related]
7. Test for recovery from hypothyroidism during thyroxine therapy in Hashimoto's thyroiditis.
Takasu N; Komiya I; Asawa T; Nagasawa Y; Yamada T
Lancet; 1990 Nov; 336(8723):1084-6. PubMed ID: 1977978
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.
Bartalena L; Martino E; Pacchiarotti A; Grasso L; Aghini-Lombardi F; Buratti L; Bambini G; Breccia M; Pinchera A
J Clin Endocrinol Metab; 1987 Apr; 64(4):849-55. PubMed ID: 3818906
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis.
Kojima N; Sakata S; Nakamura S; Nagai K; Takuno H; Ogawa T; Matsui I; Sarui H; Miura K
J Endocrinol Invest; 1992; 15(7):491-6. PubMed ID: 1447487
[TBL] [Abstract][Full Text] [Related]
10. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism.
Maeda M; Kuzuya N; Masuyama Y; Imai Y; Ikeda H
J Clin Endocrinol Metab; 1976 Jul; 43(1):10-7. PubMed ID: 947930
[TBL] [Abstract][Full Text] [Related]
11. Response to thyrotropin releasing hormone: an objective criterion for the adequacy of thyrotropin suppression therapy.
Hoffman DP; Surks MI; Oppenheimer JH; Weitzman ED
J Clin Endocrinol Metab; 1977 May; 44(5):892-901. PubMed ID: 404309
[TBL] [Abstract][Full Text] [Related]
12. Studies on replacement and suppressive dosages of 1-thyroxine.
Nilsson G; Pettersson U; Levin K; Hughes R
Acta Med Scand; 1977; 202(4):257-60. PubMed ID: 920242
[TBL] [Abstract][Full Text] [Related]
13. Acute effect of exogenous thyroxine dose on serum thyroxine and thyrotrophin levels in treated hypothyroid patients.
Soppi E; Irjala K; Kaihola HL; Viikari J
Scand J Clin Lab Invest; 1984 Jun; 44(4):353-6. PubMed ID: 6463564
[TBL] [Abstract][Full Text] [Related]
14. Difference in pituitary-thyroid feedback regulation in hypothyroid patients, depending on the severity of hypothyroidism.
Aizawa T; Koizumi Y; Yamada T; Tawata M; Nagata H; Izumiyama T; Yoshizawa K
J Clin Endocrinol Metab; 1978 Sep; 47(3):560-5. PubMed ID: 263732
[TBL] [Abstract][Full Text] [Related]
15. Congenital goitrous hypothyroidism: discordant systolic time intervals, pituitary and peripheral responses to high daily doses of T4 or T3 therapy.
Cavaliere H; Savioli R; Lima E; Medeiros-Neto GA
J Endocrinol Invest; 1984 Aug; 7(4):367-72. PubMed ID: 6438221
[TBL] [Abstract][Full Text] [Related]
16. Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study.
Del Duca SC; Santaguida MG; Brusca N; Gatto I; Cellini M; Gargano L; Verga Falzacappa C; Frattaroli FM; Virili C; Centanni M
Eur J Endocrinol; 2015 Sep; 173(3):351-7. PubMed ID: 26092761
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
Bayer MF; Kriss JP; McDougall IR
J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
[TBL] [Abstract][Full Text] [Related]
18. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
[TBL] [Abstract][Full Text] [Related]
19. Thyroxine may decrease serum thyroxine-binding globulin levels.
Lin JY; Hwu-Liaw SE; Chang TC
Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):342-5. PubMed ID: 2507733
[TBL] [Abstract][Full Text] [Related]
20. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine.
Fiore E; Rago T; Latrofa F; Provenzale MA; Piaggi P; Delitala A; Scutari M; Basolo F; Di Coscio G; Grasso L; Pinchera A; Vitti P
Endocr Relat Cancer; 2011 Aug; 18(4):429-37. PubMed ID: 21565972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
